KH

Karl Handelsman

Founder & Managing Partner, Codon Capital

San Francisco, California

CEO

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Entrepreneurship
Venture Capital
Start-ups
Commercialization
Lifesciences
Corporate Development
Life Sciences
Pharmaceutical Industry
Mergers & Acquisitions
Technology Transfer
Business Development
Private Equity
Strategy
Strategic Partnerships
Due Diligence
Drug Discovery
Drug Development
Angel Investing
Start-up Ventures

Education

Investments

Bonum Therapeutics

Series A

Total Funding: $93M

Clear Labs

Series B

Total Funding: $140M

Work Experience

UCSF

2013

  • Catalyst Advisory Panel

    2013

    http://ctsi.ucsf.edu/

  • Lean Launchpad for Therapeutics/Tools Instructor

    2013 - 2016

    http://ita.ucsf.edu/entrepreneurship-center/education/courses/lean-launchpad-life-science-healthcare

Stanford University

2013

  • SPARK Selection Committee

    2013

    Evaluate IP from Stanford College of Medicine program for development and commercialization. http://sparkmed.stanford.edu/

Life Science Angels

2014

  • Member

    2014

Codon Capital

2013

  • Founder & Investor

    2013

    Series A investing and building therapeutic and synthetic biology companies with focus on human and planetary health. www.codoncapital.com

Genentech

2016 - 2021

  • Senior Advisor, Roche Venture Fund

    2016 - 2021

    Roche Venture Fund is a $500M evergreen fund, I specialize in pre-clinical stage drug discovery.

California Inst. for Regenerative Medicine

2013 - 2016

  • Mentor

    2013 - 2016

CMEA Capital

1999 - 2014

  • General Partner Emeritus

    2013 - 2014

  • Managing Director/General Partner

    1999 - 2013

Millennium Pharmaceuticals

1996 - 1997

  • Director, Business Development

    1996 - 1997

Tularik

1992 - 1996

  • Manager, Business Development

    1992 - 1996